Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEquity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Chs (CHSCN) Cost of Revenue (2016 - 2026)

Chs (CHSCN) has disclosed Cost of Revenue for 17 consecutive years, with $8.3 billion as the latest value for Q1 2026.

  • Quarterly Cost of Revenue rose 7.88% to $8.3 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $34.5 billion through Feb 2026, changed 0.41% year-over-year, with the annual reading at $34.3 billion for FY2025, 8.49% down from the prior year.
  • Cost of Revenue hit $8.3 billion in Q1 2026 for Chs, down from $8.5 billion in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $12.7 billion in Q3 2022 to a low of $7.7 billion in Q1 2025.
  • Historically, Cost of Revenue has averaged $9.8 billion across 5 years, with a median of $9.1 billion in 2024.
  • Biggest five-year swings in Cost of Revenue: rose 25.89% in 2022 and later decreased 28.98% in 2023.
  • Year by year, Cost of Revenue stood at $11.9 billion in 2022, then dropped by 9.6% to $10.7 billion in 2023, then decreased by 17.24% to $8.9 billion in 2024, then decreased by 4.71% to $8.5 billion in 2025, then dropped by 1.73% to $8.3 billion in 2026.
  • Business Quant data shows Cost of Revenue for CHSCN at $8.3 billion in Q1 2026, $8.5 billion in Q4 2025, and $8.3 billion in Q3 2025.